Results 1 to 10 of about 192,256 (352)

An Epidemiological Study of Neuropathic Pain Symptoms in Canadian Adults [PDF]

open access: yesPain Research and Management, 2016
The reported prevalence of neuropathic pain ranges from 6.9% to 10%; however the only Canadian study reported 17.9%. The objective of this study was to describe the epidemiology of neuropathic pain in Canada.
Elizabeth G. VanDenKerkhof   +5 more
doaj   +7 more sources

Cross-sectional comparison of cannabis use in adults with neuropathic versus non-neuropathic pain [PDF]

open access: yesFrontiers in Pain Research
IntroductionCannabis has been decriminalized by many states and shows promise in treating both neuropathic and non-neuropathic pain through its interaction with the endocannabinoid system and anti-inflammatory effects.
Carl Joshua P. Laroya   +7 more
doaj   +2 more sources

Neuropathic pain

open access: yesИнновационная медицина Кубани, 2021
Background Chronic neuropathic pain is a common occurrence, its prevalence ranges from 7 to 10% of the total population. Currently, the only official document that includes neuropathic pain is the International Classification of Headaches Disorders (ICHD-
V. A. Koriachkin   +2 more
doaj   +3 more sources

Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain? [PDF]

open access: yesJournal of Pain Research, 2013
Kai-Uwe Kern,1 Srinivas Nalamachu,2 Louis Brasseur,3 Joanna M Zakrzewska4 1Institute for Pain Medicine, Wiesbaden, Germany; 2International Clinical Research Institute, Overland Park, KS, USA; 3Institut Curie, Saint Cloud, France; 4Eastman Dental Hospital,
Kern KU   +3 more
doaj   +3 more sources

Comparing objective cognitive impairments in patients with peripheral neuropathic pain or fibromyalgia

open access: yesScientific Reports, 2021
Existing studies on cognitive impairments in chronic pain do not investigate peripheral neuropathic pain (PNP) or compare pain conditions in a satisfactory manner. Here we aimed to compare executive dysfunctions in PNP patients with fibromyalgia (FM) and
Henrik Børsting Jacobsen   +4 more
doaj   +1 more source

Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol

open access: yesTrials, 2022
Background Patients with chronic idiopathic axonal polyneuropathy (CIAP) can have neuropathic pain that significantly impacts quality of life. Oral neuropathic pain medication often has insufficient pain relief and side effects.
David J. Kopsky   +5 more
doaj   +1 more source

Trigeminal neuralgia: new classification and diagnostic grading for practice and research [PDF]

open access: yes, 2016
Trigeminal neuralgia (TN) is an exemplary condition of neuropathic facial pain. However, formally classifying TN as neuropathic pain based on the grading system of the International Association for the Study of Pain is complicated by the requirement of ...
CRUCCU, Giorgio   +8 more
core   +4 more sources

Relationship between Nontraumatic Shoulder Disorders and Neuropathic Pain: Retrospective Observational Analyses of Clinical Features and Background Factors

open access: yesAnesthesiology Research and Practice, 2023
Background. Accurate identification of neuropathic pain is necessary for appropriate treatment; however, the relationship between nontraumatic shoulder disorders and neuropathic pain remains unknown.
Tsuyoshi Sasaki   +9 more
doaj   +1 more source

Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain. An observational analysis [PDF]

open access: yes, 2016
INTRODUCTION: Cancer-related pain has a severe negative impact on quality of life. Combination analgesic therapy with oxycodone and pregabalin is effective for treating neuropathic cancer pain.
Borghesi, Cristina   +6 more
core   +2 more sources

Phenytoin Cream for the Treatment of Neuropathic Pain: Case Series

open access: yesPharmaceuticals, 2018
BACKGROUND: Neuropathic pain can be disabling, and is often difficult to treat. Within a year, over half of all patients stop taking their prescribed neuropathic pain medication, which is most probably due to side effects or disappointing analgesic ...
David J. Kopsky, Jan M. Keppel Hesselink
doaj   +1 more source

Home - About - Disclaimer - Privacy